{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:13:57Z","timestamp":1791335637602,"version":"4.3.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T00:00:00Z","timestamp":1463702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00262-016-1844-3","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T23:00:41Z","timestamp":1463871641000},"page":"909-917","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor"],"prefix":"10.1007","volume":"65","author":[{"given":"Silvio","family":"Roncella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristiana","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Varesano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Boccardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Vigani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Aldo","family":"Canessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Giannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Fedeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico Franco","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Ceppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Riggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Romani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Saverino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Poggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Pistillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,20]]},"reference":[{"key":"1844_CR1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA (2005) Advances in malignant mesothelioma. N Engl J Med 353:1591\u20131603","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"1844_CR2","first-page":"S397","volume":"5","author":"K Porpodis","year":"2013","unstructured":"Porpodis K, Zarogoulidis P, Boutsikou E, Papaioannou A, Machairiotis N, Tsakiridis K, Katsikogiannis N, Zaric B, Perin B, Huang H et al (2013) Malignant pleural mesothelioma: current and future perspectives. J Thorac Dis 5(Suppl 4):S397\u2013S406","journal-title":"J Thorac Dis"},{"key":"1844_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/107327480601300402","volume":"13","author":"R Ismail-Khan","year":"2006","unstructured":"Ismail-Khan R, Robinson LA, Williams CC Jr, Garrett CR, Bepler G, Simon GR (2006) Malignant pleural mesothelioma: a comprehensive review. Cancer Control 13:255\u2013263","journal-title":"Cancer Control"},{"key":"1844_CR4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ctrv.2014.10.007","volume":"41","author":"J Remon","year":"2015","unstructured":"Remon J, Reguart N, Corral J, Lianes P (2015) Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategies. Cancer Treat Rev 41:27\u201334","journal-title":"Cancer Treat Rev"},{"key":"1844_CR5","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.4049\/jimmunol.175.11.7746","volume":"175","author":"AV Maker","year":"2005","unstructured":"Maker AV, Attia P, Rosenberg SA (2005) Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade. J Immunol 175:7746\u20137754","journal-title":"J Immunol"},{"key":"1844_CR6","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S1470-2045(13)70381-4","volume":"14","author":"L Calabr\u00f2","year":"2013","unstructured":"Calabr\u00f2 L, Morra A, Fonsatti E, Cutaia O, Amato G, Giannarelli D, Di Giacomo AM, Danielli R, Altomonte M, Mutti L, Maio M (2013) Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial. Lancet Oncol 14:1104\u20131111","journal-title":"Lancet Oncol"},{"key":"1844_CR7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-2600(15)00092-2","volume":"3","author":"L Calabr\u00f2","year":"2015","unstructured":"Calabr\u00f2 L, Morra A, Fonsatti E, Cutaia O, Fazio C, Annesi D, Lenoci M, Amato G, Danielli R, Altomonte M et al (2015) Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study. Lancet Respir Med 3:301\u2013309","journal-title":"Lancet Respir Med"},{"key":"1844_CR8","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nri3108","volume":"11","author":"LS Walker","year":"2011","unstructured":"Walker LS, Sansom DM (2011) The emerging role of CTLA-4 as a cell-extrinsic regulator of T cell responses. Nat Rev Immunol 11:852\u2013863","journal-title":"Nat Rev Immunol"},{"key":"1844_CR9","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1084\/jem.183.6.2533","volume":"183","author":"MF Krummel","year":"1996","unstructured":"Krummel MF, Allison JP (1996) CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 183:2533\u20132540","journal-title":"J Exp Med"},{"key":"1844_CR10","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.4049\/jimmunol.162.10.5813","volume":"162","author":"MC Brunner","year":"1999","unstructured":"Brunner MC, Chambers CA, Chan FK, Hanke J, Winoto A, Allison JP (1999) CTLA-4-mediated inhibition of early events of T cell proliferation. J Immunol 162:5813\u20135820","journal-title":"J Immunol"},{"key":"1844_CR11","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4049\/jimmunol.177.2.1052","volume":"177","author":"JJ Engelhardt","year":"2006","unstructured":"Engelhardt JJ, Sullivan TJ, Allison JP (2006) CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism. J Immunol 177:1052\u20131061","journal-title":"J Immunol"},{"key":"1844_CR12","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.4049\/jimmunol.181.3.1683","volume":"181","author":"Y Zheng","year":"2008","unstructured":"Zheng Y, Manzotti CN, Burke F, Dussably L, Qureshi O, Walker LS, Sansom DM (2008) Acquisition of suppressive function by activated human CD4\u00a0+\u00a0CD25- T cells is associated with the expression of CTLA-4 not FoxP3. J Immunol 181:1683\u20131691","journal-title":"J Immunol"},{"key":"1844_CR13","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.4049\/jimmunol.164.10.5015","volume":"164","author":"MK Oaks","year":"2000","unstructured":"Oaks MK, Hallett KM (2000) Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol 164:5015\u20135018","journal-title":"J Immunol"},{"key":"1844_CR14","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/eji.201242529","volume":"43","author":"FJ Ward","year":"2013","unstructured":"Ward FJ, Dahal LN, Wijesekera SK, Abdul-Jawad SK, Kaewarpai T, Xu H, Vickers MA, Barker RN (2013) The soluble isoform of CTLA-4 as a regulator of T-cell responses. Eur J Immunol 43:1274\u20131285","journal-title":"Eur J Immunol"},{"key":"1844_CR15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.clim.2007.01.003","volume":"123","author":"D Saverino","year":"2007","unstructured":"Saverino D, Brizzolara R, Simone R, Chiappori A, Milintenda-Floriani F, Pesce G, Bagnasco M (2007) Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation. Clin Immunol 123:190\u2013198","journal-title":"Clin Immunol"},{"key":"1844_CR16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/intimm\/dxp069","volume":"21","author":"R Simone","year":"2009","unstructured":"Simone R, Brizzolara R, Chiappori A, Milintenda-Floriani F, Natale C, Greco L, Schiavo M, Bagnasco M, Pesce G, Saverino D (2009) A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury. Int Immunol 21:1037\u20131045","journal-title":"Int Immunol"},{"key":"1844_CR17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","volume":"423","author":"H Ueda","year":"2003","unstructured":"Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G et al (2003) Association of the T-cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature 423:506\u2013511","journal-title":"Nature"},{"issue":"9","key":"1844_CR18","doi-asserted-by":"crossref","first-page":"e44654","DOI":"10.1371\/journal.pone.0044654","volume":"7","author":"R Simone","year":"2012","unstructured":"Simone R, Tenca C, Fais F, Luciani M, De Rossi G, Pesce G, Bagnasco M, Saverino D (2012) A soluble form of CTLA-4 is present in paediatric patients with acute lymphoblastic leukaemia and correlates with CD1d\u00a0+\u00a0expression. PLoS One 7(9):e44654","journal-title":"PLoS One"},{"key":"1844_CR19","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3109\/07357901003630934","volume":"28","author":"N Erfani","year":"2010","unstructured":"Erfani N, Razmkhah M, Ghaderi A (2010) Circulating soluble CTLA-4 (sCTLA-4) is elevated in patients with breast cancer. Cancer Invest 28:828\u2013832","journal-title":"Cancer Invest"},{"key":"1844_CR20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ijc.21155","volume":"117","author":"E Contardi","year":"2005","unstructured":"Contardi E, Palmisano GL, Tazzari PL, Martelli AM, Fal\u00e0 F, Fabbi M, Kato T, Lucarelli E, Donati D, Polito L et al (2005) CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction. Int J Cancer 117:538\u2013550","journal-title":"Int J Cancer"},{"key":"1844_CR21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1479-5876-11-108","volume":"11","author":"S Laurent","year":"2013","unstructured":"Laurent S, Queirolo P, Boero S, Salvi S, Piccioli P, Boccardo S, Minghelli S, Morabito A, Fontana V, Pietra G et al (2013) The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-\u03b1 production. J Transl Med 11:108","journal-title":"J Transl Med"},{"key":"1844_CR22","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00262-012-1211-y","volume":"61","author":"S Salvi","year":"2012","unstructured":"Salvi S, Fontana V, Boccardo S, Merlo DF, Margallo E, Laurent S, Morabito A, Rijavec E, Dal Bello MG, Mora M, Ratto GB, Grossi F, Truini M, Pistillo MP (2012) Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer. Cancer Immunol Immunother 61:1463\u20137214","journal-title":"Cancer Immunol Immunother"},{"key":"1844_CR23","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1038\/jid.2008.170","volume":"128","author":"KV Shah","year":"2008","unstructured":"Shah KV, Chien AJ, Yee C, Moon RT (2008) CTLA-4 is a direct target of Wnt\/beta-catenin signalling and is expressed in human melanoma tumors. J Invest Dermatol 128:2870\u20132879","journal-title":"J Invest Dermatol"},{"key":"1844_CR24","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2174\/156800910793605811","volume":"10","author":"H Mao","year":"2010","unstructured":"Mao H, Zhang L, Yang Y, Zuo W, Bi Y, Gao W, Deng B, Sun J, Shao Q, Qu X (2010) New insights of CTLA-4 into its biological function in breast cancer. Curr Cancer Drug Targets 10:728\u2013736","journal-title":"Curr Cancer Drug Targets"},{"key":"1844_CR25","doi-asserted-by":"crossref","first-page":"576486","DOI":"10.1155\/2013\/576486","volume":"2013","author":"A Antczak","year":"2013","unstructured":"Antczak A, Pastuszak-Lewandoska D, G\u00f3rski P, Doma\u0144ska D, Migdalska-S\u0119k M, Czarnecka K, Nawrot E, Kordiak J, Brzezia\u0144ska E (2013) CTLA-4 expression and polymorphisms in lung tissue of patients with diagnosed non-small-cell lung cancer. Biomed Res Int 2013:576486","journal-title":"Biomed Res Int"},{"key":"1844_CR26","volume-title":"Analysing survival data from clinical trials and observational studies","author":"E Marubini","year":"2004","unstructured":"Marubini E, Valsecchi MG (2004) Analysing survival data from clinical trials and observational studies. Wiley & Sons, New York"},{"key":"1844_CR27","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1016\/j.csda.2007.09.003","volume":"52","author":"H Liang","year":"2008","unstructured":"Liang H, Zou G (2008) Improved AIC selection strategy for survival analysis. Comput Stat Data Anal 52:2538\u20132548","journal-title":"Comput Stat Data Anal"},{"key":"1844_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1214\/ss\/1032280214","volume":"11","author":"TJ DiCiccio","year":"1996","unstructured":"DiCiccio TJ, Efron B (1996) Bootstrap confidence intervals. Stat Sci 11:189\u2013228","journal-title":"Stat Sci"},{"key":"1844_CR29","doi-asserted-by":"crossref","first-page":"25107","DOI":"10.1074\/jbc.270.42.25107","volume":"270","author":"HT Leung","year":"1995","unstructured":"Leung HT, Bradshaw J, Cleaveland JS, Linsley PS (1995) Cytotoxic T lymphocyte-associated molecule-4, a high-avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. J Biol Chem 270:25107\u201325114","journal-title":"J Biol Chem"},{"key":"1844_CR30","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1182\/blood-2011-11-388918","volume":"119","author":"X Tai","year":"2012","unstructured":"Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB et al (2012) Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood 119:5155\u20135163","journal-title":"Blood"},{"key":"1844_CR31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.trsl.2009.12.001","volume":"155","author":"L Vald\u00e9s","year":"2010","unstructured":"Vald\u00e9s L, San-Jos\u00e9 E, Est\u00e9vez JC, Gonz\u00e1lez-Barcala FJ, Alvarez-Doba\u00f1o JM, Golpe A, Valle JM, Penela P, Vizca\u00edno L, Pose A (2010) Cholesterol in pleural exudates depends mainly on increased capillary permeability. Transl Res 155:178\u2013184","journal-title":"Transl Res"},{"key":"1844_CR32","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1164\/rccm.200504-588OC","volume":"172","author":"YQ Chen","year":"2005","unstructured":"Chen YQ, Shi HZ, Qin XJ, Mo WN, Liang XD, Huang ZX, Yang HB, Wu C (2005) CD4\u00a0+\u00a0CD25\u00a0+\u00a0regulatory T lymphocytes in malignant pleural effusion. Am J Respir Crit Care Med 172:1434\u20131439","journal-title":"Am J Respir Crit Care Med"},{"key":"1844_CR33","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4049\/jimmunol.1303389","volume":"193","author":"L Esposito","year":"2014","unstructured":"Esposito L, Hunter KM, Clark J, Rainbow DB, Stevens H, Denesha J, Duley S, Dawson S, Coleman G, Nutland S et al (2014) Investigation of soluble and transmembrane CTLA-4 isoforms in serum and microvesicles. J Immunol 193:889\u2013900","journal-title":"J Immunol"},{"key":"1844_CR34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.micpath.2011.06.003","volume":"51","author":"J Cao","year":"2011","unstructured":"Cao J, Zhang L, Huang S, Chen P, Zou L, Chen H, Xiang Y, Lai X, Ren G (2011) Aberrant production of soluble co-stimulatory molecules CTLA-4 and CD28 in patients with chronic hepatitis B. Microb Pathog 51:262\u2013267","journal-title":"Microb Pathog"},{"key":"1844_CR35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2249.2001.01575.x","volume":"126","author":"K Steiner","year":"2001","unstructured":"Steiner K, Moosig F, Csernok E, Selleng K, Gross WL, Fleischer B, Br\u00f6ker BM (2001) Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener\u2019s granulomatosis. Clin Exp Immunol 126:143\u2013150","journal-title":"Clin Exp Immunol"},{"key":"1844_CR36","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/resp.12113","volume":"18","author":"Y Shen","year":"2013","unstructured":"Shen Y, Yang T, Wang T, Chen L, Wen F (2013) Elevated circulating cytotoxic T lymphocyte-associated antigen-4 levels are related to lung function and inflammation in chronic obstructive pulmonary disease. Respirology 18:885\u2013886","journal-title":"Respirology"},{"key":"1844_CR37","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1183\/09031936.00000811","volume":"38","author":"AW Musk","year":"2011","unstructured":"Musk AW, Olsen N, Alfonso H, Reid A, Mina R, Franklin P, Sleith J, Hammond N, Threlfall T, Shilkin KB, de Klerk NH (2011) Predicting survival in malignant mesothelioma. Eur Respir J 38:1420\u20131424","journal-title":"Eur Respir J"},{"key":"1844_CR38","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1517\/14712598.2015.1116515","volume":"15","author":"A Guazzelli","year":"2015","unstructured":"Guazzelli A, Hussain M, Krstic-Demonacos M, Mutti L (2015) Tremelimumab for the treatment of malignant mesothelioma. Expert Opin Biol Ther 15:1819\u20131829","journal-title":"Expert Opin Biol Ther"},{"key":"1844_CR39","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2217\/imt.14.73","volume":"6","author":"FJ Ward","year":"2014","unstructured":"Ward FJ, Dahal LN, Khanolkar RC, Shankar SP, Barker RN (2014) Targeting the alternatively spliced soluble isoform of CTLA-4: prospects for immunotherapy? Immunotherapy 6:1073\u20131084","journal-title":"Immunotherapy"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1844-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-016-1844-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1844-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T12:55:42Z","timestamp":1692363342000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-016-1844-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,20]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["1844"],"URL":"https:\/\/doi.org\/10.1007\/s00262-016-1844-3","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,20]]}}}